|From: NetworkNewsWire (Rep: 0)||Date: 10/22/2019 16:33|
|Forum: Wall Street Pit - Msg #2802895 - List INMB msgs ||Thread #674104451 (Rec: 0) |
|NetworkNewsBreaks – INmune Bio, Inc.’s (NASDAQ: INMB) XPro1595 Highlighted During Press Conference at the Society for Neuroscience 49th Annual Meeting|
INmune Bio (NASDAQ: INMB) on Monday announced that Malú Tansey, Ph.D., Professor of Neuroscience and Director of the Center for Translational Research in Neurodegenerative Disease at the University of Florida College of Medicine, presented data that demonstrated the use of INmune Bio’s lead compound, XPro1595, to lessen the exacerbation of Alzheimer’s-like pathology brought on by a high fat and high fructose diet in mice. Dr. Tansey presented the data as the lead speaker at a press conference during the Society for Neuroscience 49th Annual Meeting in Chicago. “The new data strengthen our findings that a potential connection between diets rich in fat and sugar and chronic inflammation can lead to an increased risk for Alzheimer’s disease,” Dr. Malú Tansey stated in the news release. “With more than 93 million obese people in the U.S., according to the most recent data from the Centers for Disease Control and Prevention, understanding the link between obesity and Alzheimer’s disease is more relevant now than ever. By targeting inflammation with XPro1595 we may be able to effectively treat neurodegenerative diseases.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.